Literature DB >> 19235142

Derivation of epicardium-derived progenitor cells (EPDCs) from adult epicardium.

Nicola Smart1, Paul R Riley.   

Abstract

The epicardium has, like the other cell lineages of the terminally differentiated adult heart, long been regarded as quiescent, incapable of migration or differentiation. In contrast, the embryonic epicardium possesses an innate ability to proliferate, migrate, and differentiate into a number of mature cardiovascular cell types, including vascular smooth muscle cells, fibroblasts, cardiomyocytes, and, arguably, some endothelial cells. In recapitulating its essential developmental role, we recognized the ability of the actin-binding peptide thymosin beta4 (Tbeta4) to induce epicardium-derived progenitor cell (EPDC) migration from adult heart and noted the derivation of cell types originating from embryonic epicardium. This protocol provides a means of enabling adult EPDC outgrowth and culture. We establish a model system in which to study the ability of factors to influence the migration of vascular precursors and their differentiation and to move towards screening of small molecules ex vivo prior to clinical trials of therapeutic cardiac repair.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235142     DOI: 10.1002/9780470151808.sc02c02s8

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  12 in total

Review 1.  Protein NMR in biomedical research.

Authors:  W Jahnke; H Widmer
Journal:  Cell Mol Life Sci       Date:  2004-02-26       Impact factor: 9.261

2.  Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity.

Authors:  H Rupp; T P Rupp; P Alter; N Jung; S Pankuweit; B Maisch
Journal:  Herz       Date:  2010-10       Impact factor: 1.443

3.  Epicardial Outgrowth Culture Assay and Ex Vivo Assessment of Epicardial-derived Cell Migration.

Authors:  Michael A Trembley; Lissette S Velasquez; Eric M Small
Journal:  J Vis Exp       Date:  2016-03-18       Impact factor: 1.355

Review 4.  Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease.

Authors:  Jason C Kovacic; Nadia Mercader; Miguel Torres; Manfred Boehm; Valentin Fuster
Journal:  Circulation       Date:  2012-04-10       Impact factor: 29.690

5.  De novo cardiomyocytes from within the activated adult heart after injury.

Authors:  Nicola Smart; Sveva Bollini; Karina N Dubé; Joaquim M Vieira; Bin Zhou; Sean Davidson; Derek Yellon; Johannes Riegler; Anthony N Price; Mark F Lythgoe; William T Pu; Paul R Riley
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

6.  Isolation and culture of mouse proepicardium using serum-free conditions.

Authors:  Robert J Garriock; Takashi Mikawa; Terry P Yamaguchi
Journal:  Methods       Date:  2013-06-29       Impact factor: 3.608

7.  miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1.

Authors:  Hasse Brønnum; Ditte C Andersen; Mikael Schneider; Maria B Sandberg; Tilde Eskildsen; Solveig B Nielsen; Raghu Kalluri; Søren P Sheikh
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

8.  Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches.

Authors:  L M Popescu; Mihaela Gherghiceanu; C G Manole; Maria Simonetta Faussone-Pellegrini
Journal:  J Cell Mol Med       Date:  2009-04-20       Impact factor: 5.310

9.  Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.

Authors:  Nicola Smart; Sveva Bollini; Karina N Dubé; Joaquim M Vieira; Bin Zhou; Johannes Riegler; Anthony N Price; Mark F Lythgoe; Sean Davidson; Derek Yellon; William T Pu; Paul R Riley
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

10.  Epicardium: interstitial Cajal-like cells (ICLC) highlighted by immunofluorescence.

Authors:  L Suciu; L M Popescu; T Regalia; A Ardelean; C G Manole
Journal:  J Cell Mol Med       Date:  2009-03-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.